This phenomenon is for instance well known in the subset of gastro-intestinal stromal tumors that are wild-type for the KIT and PDGFRA genes and generally do not respond to TKIs such as Imatinib and Sunitinib. The gene discussed is PDGFRA; the disease is gastrointestinal stromal tumor.